Gene · 3741
Papers2,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of Nod-like receptor protein 3 inflammasome activated by ion channels in multiple diseases. | Mol Cell Biochem | 2023 | 36378463 | PubTator, text mining | PubMed |
| Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH. | Eur Respir J | 2023 | 36302552 | PubTator, text mining | PubMed |
| A rare homozygous missense GDF2 (BMP9) mutation causing PAH in siblings: Does BMP10 status contribute? | Am J Med Genet A | 2023 | 36259599 | PubTator, text mining | PubMed |
| Placental ion channels: potential target of chemical exposure. | Biol Reprod | 2023 | 36173899 | PubTator, text mining | PubMed |
| Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology. | Nat Rev Cardiol | 2023 | 36109633 | PubTator, text mining | PubMed |
| Network-Based Data Analysis Reveals Ion Channel-Related Gene Features in COVID-19: A Bioinformatic Approach. | Biochem Genet | 2023 | 36104591 | PubTator, text mining | PubMed |
| Lipid Levels and New-Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction. | J Atheroscler Thromb | 2023 | 35871559 | PubTator, text mining | PubMed |
| The inhibitory effects of pimozide, an antipsychotic drug, on voltage-gated K+ channels in rabbit coronary arterial smooth muscle cells. | Drug Chem Toxicol | 2023 | 35317682 | PubTator, text mining | PubMed |
| Evaluating the Differential Expression of miR-146a, miR-222, and miR-9 in Matched Serum and Follicular Fluid of Polycystic Ovary Syndrome Patients: Profiling and Predictive Value. | Int J Mol Cell Med | 2022 | 37727646 | PubTator, text mining | PubMed |
| Green synthesis of hyaluronic acid coated, thiolated chitosan nanoparticles for CD44 targeted delivery and sustained release of Cisplatin in cervical carcinoma. | Front Pharmacol | 2022 | 36712656 | PubTator, text mining | PubMed |
| Potassium channels: Novel targets for tumor diagnosis and chemoresistance. | Front Oncol | 2022 | 36703789 | PubTator, text mining | PubMed |
| Evaluation of Cell-Free Synthesized Human Channel Proteins for In Vitro Channel Research. | Membranes (Basel) | 2022 | 36676855 | PubTator, text mining | PubMed |
| A KCNB1 gain of function variant causes developmental delay and speech apraxia but not seizures. | Front Pharmacol | 2022 | 36618935 | PubTator, text mining | PubMed |
| Evolutionary Analysis of TCGA Data Using Over- and Under- Mutated Genes Identify Key Molecular Pathways and Cellular Functions in Lung Cancer Subtypes. | Cancers (Basel) | 2022 | 36612014 | PubTator, text mining | PubMed |
| Case report: Rescue treatment with add-on selexipag in a preterm infant with suprasystemic pulmonary hypertension, pulmonary capillary hemangiomatosis, and isolated pulmonary vein stenosis. | Front Cardiovasc Med | 2022 | 36568561 | PubTator, text mining | PubMed |
| Modeling cartilage pathology in mucopolysaccharidosis VI using iPSCs reveals early dysregulation of chondrogenic and metabolic gene expression. | Front Bioeng Biotechnol | 2022 | 36561048 | PubTator, text mining | PubMed |
| Cyclodextrins: Only Pharmaceutical Excipients or Full-Fledged Drug Candidates? | Pharmaceutics | 2022 | 36559052 | PubTator, text mining | PubMed |
| Association between Genotype, Presentation, and Outcome in Childhood Idiopathic and Hereditary Pulmonary Arterial Hypertension. | J Clin Med | 2022 | 36555947 | PubTator, text mining | PubMed |
| Alarmins as a Possible Target of Future Therapies for Atrial Fibrillation. | Int J Mol Sci | 2022 | 36555588 | PubTator, text mining | PubMed |
| Contributions of SGK3 to transporter-related diseases. | Front Cell Dev Biol | 2022 | 36531961 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3741/papers?page=12